167 related articles for article (PubMed ID: 12576769)
1. [Development of formulation of hipromellose eye drops (artificial tears)].
Inkeniene AM; Klimas R; Briedis V; Maciulevicius J
Medicina (Kaunas); 2003; 39(1):77-82. PubMed ID: 12576769
[TBL] [Abstract][Full Text] [Related]
2. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Wiśniewski A; Knioła D; Olejniczak M
Acta Pol Pharm; 2011; 68(4):555-64. PubMed ID: 21796938
[TBL] [Abstract][Full Text] [Related]
3. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
[TBL] [Abstract][Full Text] [Related]
4. [Development of technology of sodium cromoglycate eye drops].
Inkeniene AM; Klimas R; Ramanauskiene K
Medicina (Kaunas); 2005; 41(7):584-91. PubMed ID: 16062026
[TBL] [Abstract][Full Text] [Related]
5. Stability of cefepime in aqueous eye drops.
Kodym A; Pawłowska M; Rumiński JK; Bartosińska A; Kieliba A
Pharmazie; 2011 Jan; 66(1):17-23. PubMed ID: 21391430
[TBL] [Abstract][Full Text] [Related]
6. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing ceftazidime.
Kodym A; Zawisza T; Napierała B; Kukuła H
Acta Pol Pharm; 2006; 63(6):507-13. PubMed ID: 17438868
[TBL] [Abstract][Full Text] [Related]
7. Influence of additives and storage temperature on physicochemical and microbiological properties of eye drops containing cefazolin.
Kodym A; Zawisza T; Buźka K; Kukuła H
Acta Pol Pharm; 2006; 63(3):225-34. PubMed ID: 20085229
[TBL] [Abstract][Full Text] [Related]
8. [Development of formulations of desmopressin intranasal drops].
Gerbutaviciene R; Klimas R; Savickas A; Maciulevicius J
Medicina (Kaunas); 2002; 38(5):545-9. PubMed ID: 12474688
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
Bozdağ S; Gümüş K; Gümüş O; Unlü N
Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
[TBL] [Abstract][Full Text] [Related]
10. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.
Kodym A; Bilski P; Domańska A; Hełminiak Ł; Jabłońska M; Jachymska A
Acta Pol Pharm; 2012; 69(1):95-105. PubMed ID: 22574512
[TBL] [Abstract][Full Text] [Related]
11. Technology of eye drops containing metronidazole.
Kodym A; Kaczyńska-Dyba E; Kubiak B; Kukuła H
Acta Pol Pharm; 2011; 68(1):109-14. PubMed ID: 21485708
[TBL] [Abstract][Full Text] [Related]
12. Stability of fortified cefazolin ophthalmic solutions prepared in artificial tears containing surfactant-based versus oxidant-based preservatives.
Rojanarata T; Tankul J; Woranaipinich C; Potawanich P; Plianwong S; Sakulma S; Saehuan C
J Ocul Pharmacol Ther; 2010 Oct; 26(5):485-90. PubMed ID: 20879806
[TBL] [Abstract][Full Text] [Related]
13. Technology of eye drops containing aloe (Aloe arborescens Mill.--Liliaceae) and eye drops containing both aloe and neomycin sulphate.
Kodym A; Marcinkowski A; Kukuła H
Acta Pol Pharm; 2003; 60(1):31-9. PubMed ID: 12848365
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
Rosenthal RA; Buck SL; Henry CL; Schlech BA
J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
[TBL] [Abstract][Full Text] [Related]
15. Development of new ophthalmic suspension prednisolone acetate 1%.
Akram M; Shyum SB; Gauhar S
Pak J Pharm Sci; 2010 Apr; 23(2):149-54. PubMed ID: 20363691
[TBL] [Abstract][Full Text] [Related]
16. Tear fluid-eye drops compatibility assessment using surface tension.
Hotujac Grgurević M; Juretić M; Hafner A; Lovrić J; Pepić I
Drug Dev Ind Pharm; 2017 Feb; 43(2):275-282. PubMed ID: 27645109
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count.
Abu Shaqra QM; Al-Groom RM; Abu Shaqra AQ
PDA J Pharm Sci Technol; 2020; 74(3):309-317. PubMed ID: 31941794
[TBL] [Abstract][Full Text] [Related]
18. Microemulsions with timolol as potential eye drops.
Malina I; Radomska-Soukharev A
Pharmazie; 2006 Jul; 61(7):650-1. PubMed ID: 16889077
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical and microbiological properties of eye drops containing cefuroxime.
Kodym A; Zawisza T; Taberska J; Kukuła H
Acta Pol Pharm; 2006; 63(4):293-9. PubMed ID: 17203867
[TBL] [Abstract][Full Text] [Related]
20. Ophthalmic preservatives and vehicles.
Mullen W; Shepherd W; Labovitz J
Surv Ophthalmol; 1973; 17(6):469-83. PubMed ID: 4213278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
